Cambrex to invest $120 million to expand API manufacturing in US
Expanding US operations to address the increased demand for API development and manufacturing
Expanding US operations to address the increased demand for API development and manufacturing
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Investment to expand manufacturing and global medicine supply capacity
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Subscribe To Our Newsletter & Stay Updated